BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28126640)

  • 1. The effect of α-synuclein on gliosis and IL-1α, TNFα, IFNγ, TGFβ expression in murine brain.
    Sznejder-Pachołek A; Joniec-Maciejak I; Wawer A; Ciesielska A; Mirowska-Guzel D
    Pharmacol Rep; 2017 Apr; 69(2):242-251. PubMed ID: 28126640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous α-Synuclein Monomers Alter Dopamine Metabolism in Murine Brain.
    Wawer A; Joniec-Maciejak I; Sznejder-Pachołek A; Schwenkgrub J; Ciesielska A; Mirowska-Guzel D
    Neurochem Res; 2016 Aug; 41(8):2102-9. PubMed ID: 27161373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
    George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
    Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
    Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
    Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and α-synuclein dysfunction in Smad3 null mice.
    Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A
    Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.
    Bantle CM; Rocha SM; French CT; Phillips AT; Tran K; Olson KE; Bass TA; Aboellail T; Smeyne RJ; Tjalkens RB
    Exp Neurol; 2021 Dec; 346():113845. PubMed ID: 34454938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
    Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
    Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
    Kuter K; Olech Ł; Głowacka U
    Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
    Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
    Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment.
    Mitra S; Chakrabarti N; Bhattacharyya A
    J Neuroinflammation; 2011 Nov; 8():163. PubMed ID: 22112368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?
    Ong LK; Zhao Z; Kluge M; TeBay C; Zalewska K; Dickson PW; Johnson SJ; Nilsson M; Walker FR
    Brain Behav Immun; 2017 Feb; 60():117-125. PubMed ID: 27717686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
    Verma DK; Seo BA; Ghosh A; Ma SX; Hernandez-Quijada K; Andersen JK; Ko HS; Kim YH
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial reactions in Parkinson's disease.
    McGeer PL; McGeer EG
    Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.